Growth Metrics

GoodRx Holdings (GDRX) Cash from Investing Activities (2019 - 2026)

GoodRx Holdings' Cash from Investing Activities history spans 7 years, with the latest figure at -$31.8 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 90.88% to -$31.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$120.0 million, a 70.53% decrease, with the full-year FY2025 number at -$120.0 million, down 70.53% from a year prior.
  • Cash from Investing Activities hit -$31.8 million in Q4 2025 for GoodRx Holdings, down from -$18.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for GDRX hit a ceiling of $1.3 million in Q4 2022 and a floor of -$163.6 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$31.8 million across 5 years, with a median of -$16.9 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: crashed 2601.97% in 2021 and later skyrocketed 113.89% in 2022.
  • Tracing GDRX's Cash from Investing Activities over 5 years: stood at -$9.3 million in 2021, then soared by 113.89% to $1.3 million in 2022, then tumbled by 1100.93% to -$12.9 million in 2023, then decreased by 29.3% to -$16.6 million in 2024, then crashed by 90.88% to -$31.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for GDRX at -$31.8 million in Q4 2025, -$18.0 million in Q3 2025, and -$18.3 million in Q2 2025.